Review



cl05008 clth  (AMS Biotechnology)


Bioz Verified Symbol AMS Biotechnology is a verified supplier
Bioz Manufacturer Symbol AMS Biotechnology manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 96

    Structured Review

    AMS Biotechnology cl05008 clth
    Cl05008 Clth, supplied by AMS Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 7 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cl05008+clth/Immortalized+Human+Pericytes/pmc10224352-57-25-22
    Average 96 stars, based on 7 article reviews
    cl05008 clth - by Bioz Stars, 2026-09
    96/100 stars

    Images

    Related Articles

    Saline:

    Article Title: Non-Invasive, Targeted Nanoparticle-Mediated Drug Delivery across a Novel Human BBB Model
    Article Snippet: .. Immortalised human brain microvascular endothelial cells (I-HBMEC) (Innoprot, Bizkaia, Spain) (P10361-1M), Immortalised human astrocytes (IA) (Innoprot, Bizkaia, Spain) (P10251-1M), CLTH/Immortalised Pericytes (IP) (Amsbio, Oxfordshire, U.K.) (CL05008-CLTH), D-MEM/F:12 (1:1) (CE) (Thermofisher, Cambridge, U.K.) (11320074), Insulin-trans-sel-G, 100× (Thermofisher, Cambridge, U.K.) (41400045), Penicillin streptomycin (PS) (Gibco, Paisley, U.K.) (15070-063), Fetal bovine serum (FBS) (Gibco, Paisley, U.K.) (A3160801), Hydrocortisone solution (50 um) (Merck, Dorset, U.K.) (H6909), Fibroblast growth factor-basic (BFGF) (Merck, Dorset, U.K.) (SRP3043), Heparin sodium salt (Merck, Dorset, U.K.) (H3149), Dulbecco’s phosphate buffered saline, M (DPBS) (Merck, Dorset, U.K.) (D8537), Accutase ® solution (Merck, Dorset, U.K.) (A6964), Tissue culture flask, 75 cm 2 growth area (T75) (Sarstedt, Leicestershire, U.K.) (83.3911.002). .. Corning TW PC membrane 6.5 mm, 0.4 μm, TCT, S (Merck, Dorset, U.K.) (CLS3413-48EA), Tissue culture, 24-flat-well sterile plate (Sarstedt, Leicestershire, U.K.) (83.3922), Magnesium sulphate (MgSO 4 ) (Merck, Dorset, U.K.) (63136), Fibronectin bovine plasma (Merck, Dorset, U.K.) (F1141), Gelatin solution Bioreagent, Type B, 2% (Merck, Dorset, U.K.) (G1393).



    Similar Products

    96
    AMS Biotechnology cl05008 clth
    Cl05008 Clth, supplied by AMS Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cl05008+clth/Immortalized+Human+Pericytes/pmc10224352-57-25-22
    Average 96 stars, based on 1 article reviews
    cl05008 clth - by Bioz Stars, 2026-09
    96/100 stars
      Buy from Supplier

    96
    AMS Biotechnology pericytes ip
    TEER (Ω/cm 2 ) of static (S) EP + A in vitro BBB model over 120 h on different substrata. Endothelial cells (E), <t>Pericytes</t> (P) and Astrocytes (A), Fibronectin (F), Gelatin (G) Fibronectin + Collagen (F + C), Fibronectin + Gelatin (F + G), n = 9 ± SD, *** = p < 0.001; statistical analysis was performed using two-way ANOVA Bonferroni post hoc tests.
    Pericytes Ip, supplied by AMS Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cl05008+clth/Immortalized+Human+Pericytes/pmc10224352-57-20-22
    Average 96 stars, based on 1 article reviews
    pericytes ip - by Bioz Stars, 2026-09
    96/100 stars
      Buy from Supplier

    Image Search Results


    TEER (Ω/cm 2 ) of static (S) EP + A in vitro BBB model over 120 h on different substrata. Endothelial cells (E), Pericytes (P) and Astrocytes (A), Fibronectin (F), Gelatin (G) Fibronectin + Collagen (F + C), Fibronectin + Gelatin (F + G), n = 9 ± SD, *** = p < 0.001; statistical analysis was performed using two-way ANOVA Bonferroni post hoc tests.

    Journal: Pharmaceutics

    Article Title: Non-Invasive, Targeted Nanoparticle-Mediated Drug Delivery across a Novel Human BBB Model

    doi: 10.3390/pharmaceutics15051382

    Figure Lengend Snippet: TEER (Ω/cm 2 ) of static (S) EP + A in vitro BBB model over 120 h on different substrata. Endothelial cells (E), Pericytes (P) and Astrocytes (A), Fibronectin (F), Gelatin (G) Fibronectin + Collagen (F + C), Fibronectin + Gelatin (F + G), n = 9 ± SD, *** = p < 0.001; statistical analysis was performed using two-way ANOVA Bonferroni post hoc tests.

    Article Snippet: Immortalised human brain microvascular endothelial cells (I-HBMEC) (Innoprot, Bizkaia, Spain) (P10361-1M), Immortalised human astrocytes (IA) (Innoprot, Bizkaia, Spain) (P10251-1M), CLTH/Immortalised Pericytes (IP) (Amsbio, Oxfordshire, U.K.) (CL05008-CLTH), D-MEM/F:12 (1:1) (CE) (Thermofisher, Cambridge, U.K.) (11320074), Insulin-trans-sel-G, 100× (Thermofisher, Cambridge, U.K.) (41400045), Penicillin streptomycin (PS) (Gibco, Paisley, U.K.) (15070-063), Fetal bovine serum (FBS) (Gibco, Paisley, U.K.) (A3160801), Hydrocortisone solution (50 um) (Merck, Dorset, U.K.) (H6909), Fibroblast growth factor-basic (BFGF) (Merck, Dorset, U.K.) (SRP3043), Heparin sodium salt (Merck, Dorset, U.K.) (H3149), Dulbecco’s phosphate buffered saline, M (DPBS) (Merck, Dorset, U.K.) (D8537), Accutase ® solution (Merck, Dorset, U.K.) (A6964), Tissue culture flask, 75 cm 2 growth area (T75) (Sarstedt, Leicestershire, U.K.) (83.3911.002).

    Techniques: In Vitro

    TEER (Ω/cm 2 ) of dynamic (D) EP + A in vitro BBB model over 120 h on different substrata. Endothelial cells (E), Pericytes (P) and Astrocytes (A), Fibronectin (F), Gelatin (G) Fibronectin + Collagen (F + C), Fibronectin + Gelatin (F + G), n = 9 ± SD, * = p < 0.05, *** = p < 0.001; statistical analysis was performed using two-way ANOVA Bonferroni post hoc tests.

    Journal: Pharmaceutics

    Article Title: Non-Invasive, Targeted Nanoparticle-Mediated Drug Delivery across a Novel Human BBB Model

    doi: 10.3390/pharmaceutics15051382

    Figure Lengend Snippet: TEER (Ω/cm 2 ) of dynamic (D) EP + A in vitro BBB model over 120 h on different substrata. Endothelial cells (E), Pericytes (P) and Astrocytes (A), Fibronectin (F), Gelatin (G) Fibronectin + Collagen (F + C), Fibronectin + Gelatin (F + G), n = 9 ± SD, * = p < 0.05, *** = p < 0.001; statistical analysis was performed using two-way ANOVA Bonferroni post hoc tests.

    Article Snippet: Immortalised human brain microvascular endothelial cells (I-HBMEC) (Innoprot, Bizkaia, Spain) (P10361-1M), Immortalised human astrocytes (IA) (Innoprot, Bizkaia, Spain) (P10251-1M), CLTH/Immortalised Pericytes (IP) (Amsbio, Oxfordshire, U.K.) (CL05008-CLTH), D-MEM/F:12 (1:1) (CE) (Thermofisher, Cambridge, U.K.) (11320074), Insulin-trans-sel-G, 100× (Thermofisher, Cambridge, U.K.) (41400045), Penicillin streptomycin (PS) (Gibco, Paisley, U.K.) (15070-063), Fetal bovine serum (FBS) (Gibco, Paisley, U.K.) (A3160801), Hydrocortisone solution (50 um) (Merck, Dorset, U.K.) (H6909), Fibroblast growth factor-basic (BFGF) (Merck, Dorset, U.K.) (SRP3043), Heparin sodium salt (Merck, Dorset, U.K.) (H3149), Dulbecco’s phosphate buffered saline, M (DPBS) (Merck, Dorset, U.K.) (D8537), Accutase ® solution (Merck, Dorset, U.K.) (A6964), Tissue culture flask, 75 cm 2 growth area (T75) (Sarstedt, Leicestershire, U.K.) (83.3911.002).

    Techniques: In Vitro

    TEER (Ω/cm 2 ) of dynamic (D) mono- and tri-culture in vitro BBB models over 120 h on Fibronectin + Gelatin (F + G) substratum combination, Endothelial cells (E), Pericytes (P) and Astrocytes (A), n = 9 ± SD, *** = p < 0.001; statistical analysis was performed using two-way ANOVA Bonferroni post hoc tests.

    Journal: Pharmaceutics

    Article Title: Non-Invasive, Targeted Nanoparticle-Mediated Drug Delivery across a Novel Human BBB Model

    doi: 10.3390/pharmaceutics15051382

    Figure Lengend Snippet: TEER (Ω/cm 2 ) of dynamic (D) mono- and tri-culture in vitro BBB models over 120 h on Fibronectin + Gelatin (F + G) substratum combination, Endothelial cells (E), Pericytes (P) and Astrocytes (A), n = 9 ± SD, *** = p < 0.001; statistical analysis was performed using two-way ANOVA Bonferroni post hoc tests.

    Article Snippet: Immortalised human brain microvascular endothelial cells (I-HBMEC) (Innoprot, Bizkaia, Spain) (P10361-1M), Immortalised human astrocytes (IA) (Innoprot, Bizkaia, Spain) (P10251-1M), CLTH/Immortalised Pericytes (IP) (Amsbio, Oxfordshire, U.K.) (CL05008-CLTH), D-MEM/F:12 (1:1) (CE) (Thermofisher, Cambridge, U.K.) (11320074), Insulin-trans-sel-G, 100× (Thermofisher, Cambridge, U.K.) (41400045), Penicillin streptomycin (PS) (Gibco, Paisley, U.K.) (15070-063), Fetal bovine serum (FBS) (Gibco, Paisley, U.K.) (A3160801), Hydrocortisone solution (50 um) (Merck, Dorset, U.K.) (H6909), Fibroblast growth factor-basic (BFGF) (Merck, Dorset, U.K.) (SRP3043), Heparin sodium salt (Merck, Dorset, U.K.) (H3149), Dulbecco’s phosphate buffered saline, M (DPBS) (Merck, Dorset, U.K.) (D8537), Accutase ® solution (Merck, Dorset, U.K.) (A6964), Tissue culture flask, 75 cm 2 growth area (T75) (Sarstedt, Leicestershire, U.K.) (83.3911.002).

    Techniques: In Vitro

    TEER (Ω/cm 2 ) of two different dynamic (D) in vitro BBB models over 120 h with and without magnesium (Mg 2+ ). Fibronectin + Gelatin (F + G), Endothelial cells (E), Pericytes (P) and Astrocytes (A). n = 9 ± SD, *** = p < 0.001; statistical analysis was performed using two-way ANOVA Bonferroni post hoc tests.

    Journal: Pharmaceutics

    Article Title: Non-Invasive, Targeted Nanoparticle-Mediated Drug Delivery across a Novel Human BBB Model

    doi: 10.3390/pharmaceutics15051382

    Figure Lengend Snippet: TEER (Ω/cm 2 ) of two different dynamic (D) in vitro BBB models over 120 h with and without magnesium (Mg 2+ ). Fibronectin + Gelatin (F + G), Endothelial cells (E), Pericytes (P) and Astrocytes (A). n = 9 ± SD, *** = p < 0.001; statistical analysis was performed using two-way ANOVA Bonferroni post hoc tests.

    Article Snippet: Immortalised human brain microvascular endothelial cells (I-HBMEC) (Innoprot, Bizkaia, Spain) (P10361-1M), Immortalised human astrocytes (IA) (Innoprot, Bizkaia, Spain) (P10251-1M), CLTH/Immortalised Pericytes (IP) (Amsbio, Oxfordshire, U.K.) (CL05008-CLTH), D-MEM/F:12 (1:1) (CE) (Thermofisher, Cambridge, U.K.) (11320074), Insulin-trans-sel-G, 100× (Thermofisher, Cambridge, U.K.) (41400045), Penicillin streptomycin (PS) (Gibco, Paisley, U.K.) (15070-063), Fetal bovine serum (FBS) (Gibco, Paisley, U.K.) (A3160801), Hydrocortisone solution (50 um) (Merck, Dorset, U.K.) (H6909), Fibroblast growth factor-basic (BFGF) (Merck, Dorset, U.K.) (SRP3043), Heparin sodium salt (Merck, Dorset, U.K.) (H3149), Dulbecco’s phosphate buffered saline, M (DPBS) (Merck, Dorset, U.K.) (D8537), Accutase ® solution (Merck, Dorset, U.K.) (A6964), Tissue culture flask, 75 cm 2 growth area (T75) (Sarstedt, Leicestershire, U.K.) (83.3911.002).

    Techniques: In Vitro

    TEER (Ω/cm 2 ) of dynamic (D) models: endothelial monolayer N/S, endothelial monolayer F + G Mg 2+ and EP + A F + G Mg 2+ . N/S = no substratum, E = endothelial cells, P = pericyte, A = astrocyte, F + G = fibronectin + gelatin and Mg = magnesium. n = 9 ± SD, *** = p < 0.001; statistical analysis was performed using two-way ANOVA Bonferroni post hoc tests.

    Journal: Pharmaceutics

    Article Title: Non-Invasive, Targeted Nanoparticle-Mediated Drug Delivery across a Novel Human BBB Model

    doi: 10.3390/pharmaceutics15051382

    Figure Lengend Snippet: TEER (Ω/cm 2 ) of dynamic (D) models: endothelial monolayer N/S, endothelial monolayer F + G Mg 2+ and EP + A F + G Mg 2+ . N/S = no substratum, E = endothelial cells, P = pericyte, A = astrocyte, F + G = fibronectin + gelatin and Mg = magnesium. n = 9 ± SD, *** = p < 0.001; statistical analysis was performed using two-way ANOVA Bonferroni post hoc tests.

    Article Snippet: Immortalised human brain microvascular endothelial cells (I-HBMEC) (Innoprot, Bizkaia, Spain) (P10361-1M), Immortalised human astrocytes (IA) (Innoprot, Bizkaia, Spain) (P10251-1M), CLTH/Immortalised Pericytes (IP) (Amsbio, Oxfordshire, U.K.) (CL05008-CLTH), D-MEM/F:12 (1:1) (CE) (Thermofisher, Cambridge, U.K.) (11320074), Insulin-trans-sel-G, 100× (Thermofisher, Cambridge, U.K.) (41400045), Penicillin streptomycin (PS) (Gibco, Paisley, U.K.) (15070-063), Fetal bovine serum (FBS) (Gibco, Paisley, U.K.) (A3160801), Hydrocortisone solution (50 um) (Merck, Dorset, U.K.) (H6909), Fibroblast growth factor-basic (BFGF) (Merck, Dorset, U.K.) (SRP3043), Heparin sodium salt (Merck, Dorset, U.K.) (H3149), Dulbecco’s phosphate buffered saline, M (DPBS) (Merck, Dorset, U.K.) (D8537), Accutase ® solution (Merck, Dorset, U.K.) (A6964), Tissue culture flask, 75 cm 2 growth area (T75) (Sarstedt, Leicestershire, U.K.) (83.3911.002).

    Techniques:

    Image of Western blot membrane, detecting ZO1 TJ-protein (mw 195 kDA) in lysed cells from different in vitro BBB models. Endothelial cells (E), Pericytes (P), Astrocytes (A), Fibronectin + Gelatin (F + G), Fibronectin + Collagen (F + C), No substrata (NS) and Magnesium (Mg 2+ ), Dynamic mode.

    Journal: Pharmaceutics

    Article Title: Non-Invasive, Targeted Nanoparticle-Mediated Drug Delivery across a Novel Human BBB Model

    doi: 10.3390/pharmaceutics15051382

    Figure Lengend Snippet: Image of Western blot membrane, detecting ZO1 TJ-protein (mw 195 kDA) in lysed cells from different in vitro BBB models. Endothelial cells (E), Pericytes (P), Astrocytes (A), Fibronectin + Gelatin (F + G), Fibronectin + Collagen (F + C), No substrata (NS) and Magnesium (Mg 2+ ), Dynamic mode.

    Article Snippet: Immortalised human brain microvascular endothelial cells (I-HBMEC) (Innoprot, Bizkaia, Spain) (P10361-1M), Immortalised human astrocytes (IA) (Innoprot, Bizkaia, Spain) (P10251-1M), CLTH/Immortalised Pericytes (IP) (Amsbio, Oxfordshire, U.K.) (CL05008-CLTH), D-MEM/F:12 (1:1) (CE) (Thermofisher, Cambridge, U.K.) (11320074), Insulin-trans-sel-G, 100× (Thermofisher, Cambridge, U.K.) (41400045), Penicillin streptomycin (PS) (Gibco, Paisley, U.K.) (15070-063), Fetal bovine serum (FBS) (Gibco, Paisley, U.K.) (A3160801), Hydrocortisone solution (50 um) (Merck, Dorset, U.K.) (H6909), Fibroblast growth factor-basic (BFGF) (Merck, Dorset, U.K.) (SRP3043), Heparin sodium salt (Merck, Dorset, U.K.) (H3149), Dulbecco’s phosphate buffered saline, M (DPBS) (Merck, Dorset, U.K.) (D8537), Accutase ® solution (Merck, Dorset, U.K.) (A6964), Tissue culture flask, 75 cm 2 growth area (T75) (Sarstedt, Leicestershire, U.K.) (83.3911.002).

    Techniques: Western Blot, Membrane, In Vitro

    Quantitative analysis of relative protein expression of ZO1 in each BBB model. Endothelial cells (E), Pericytes (P), Astrocytes (A), Fibronectin + Gelatin (F + G), Fibronectin + Collagen (F + C), No substrata (NS) and Magnesium (Mg 2+ ). n = 3, *** = p < 0.001; statistical analysis was performed using one-way ANOVA Bonferroni post hoc tests.

    Journal: Pharmaceutics

    Article Title: Non-Invasive, Targeted Nanoparticle-Mediated Drug Delivery across a Novel Human BBB Model

    doi: 10.3390/pharmaceutics15051382

    Figure Lengend Snippet: Quantitative analysis of relative protein expression of ZO1 in each BBB model. Endothelial cells (E), Pericytes (P), Astrocytes (A), Fibronectin + Gelatin (F + G), Fibronectin + Collagen (F + C), No substrata (NS) and Magnesium (Mg 2+ ). n = 3, *** = p < 0.001; statistical analysis was performed using one-way ANOVA Bonferroni post hoc tests.

    Article Snippet: Immortalised human brain microvascular endothelial cells (I-HBMEC) (Innoprot, Bizkaia, Spain) (P10361-1M), Immortalised human astrocytes (IA) (Innoprot, Bizkaia, Spain) (P10251-1M), CLTH/Immortalised Pericytes (IP) (Amsbio, Oxfordshire, U.K.) (CL05008-CLTH), D-MEM/F:12 (1:1) (CE) (Thermofisher, Cambridge, U.K.) (11320074), Insulin-trans-sel-G, 100× (Thermofisher, Cambridge, U.K.) (41400045), Penicillin streptomycin (PS) (Gibco, Paisley, U.K.) (15070-063), Fetal bovine serum (FBS) (Gibco, Paisley, U.K.) (A3160801), Hydrocortisone solution (50 um) (Merck, Dorset, U.K.) (H6909), Fibroblast growth factor-basic (BFGF) (Merck, Dorset, U.K.) (SRP3043), Heparin sodium salt (Merck, Dorset, U.K.) (H3149), Dulbecco’s phosphate buffered saline, M (DPBS) (Merck, Dorset, U.K.) (D8537), Accutase ® solution (Merck, Dorset, U.K.) (A6964), Tissue culture flask, 75 cm 2 growth area (T75) (Sarstedt, Leicestershire, U.K.) (83.3911.002).

    Techniques: Expressing